Key Roles for MYC, KIT and RET signaling in secondary angiosarcomas

British Journal of Cancer

Volumn 111, Issue 2, 2014, Pages 407-412

  Styring, E ^a   Seinen, J ^b   Dominguez Valentin, M ^a   Domanski, H A ^a   Jonsson M ^a   Von Steyern, F V ^a   Hoekstra, H J ^b   Suurmeijer, A J H ^b   Nilbert, M ^a,c  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

CDKN2C; gene expression; KDR; KIT; MYC; radiation associated; tyrosine kinase receptor

Indexed keywords

GENOMIC DNA; MYC PROTEIN; PROTEIN TYROSINE KINASE;

ADULT; AGED; ANALYSIS; ANGIOSARCOMA; ARTICLE; CHILD; CLINICAL ARTICLE; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE TARGETING; GENOME; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; ONCOGENE RET; PRESCHOOL CHILD; PRIMARY TUMOR; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; TUMOR GENE; UPREGULATION; VALIDATION STUDY; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; GENE AMPLIFICATION; GENES, MYC; GENOME, HUMAN; HEMANGIOSARCOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PROTO-ONCOGENE PROTEINS C-KIT; PROTO-ONCOGENE PROTEINS C-RET; YOUNG ADULT;

EID: 84904566344     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.359     Document Type: Article

References (37)

1. Antonescu CR, Yoshida A, Guo T, Chang NE, Zhang L, Agaram NP, Qin LX, Brennan MF, Singer S, Maki RG (2009) KDR activating mutations in human angiosarcomas are sensitive to specific kinase inhibitors. Cancer Res 69: 7175-7179.
2. Arlen M, Higinbotham NL, Huvos AG, Marcove RC, Miller T, Shah IC (1971) Radiation-induced sarcoma of bone. Cancer 28: 1087-1099.
3. Billings SD, McKenney JK, Folpe AL, Hardacre MC, Weiss SW (2004) Cutaneous angiosarcoma following breast-conserving surgery and radiation: an analysis of 27 cases. Am J Surg Pathol 28: 781-788.
4. Body G, Sauvanet E, Calais G, Fignon A, Fetissof F, Lansac J (1987) [Cutaneous angiosarcoma of the breast following surgery and irradiation of breast adenocarcinoma]. J Gynecol Obstet Biol Reprod (Paris) 16: 479-483.
5. Bounacer A, Wicker R, Schlumberger M, Sarasin A, Suarez HG (1997) Oncogenic rearrangements of the ret proto-oncogene in thyroid tumors induced after exposure to ionizing radiation. Biochimie 79: 619-623.
6. Brenn T, Fletcher CD (2005) Radiation-associated cutaneous atypical vascular lesions and angiosarcoma: clinicopathologic analysis of 42 cases. Am J Surg Pathol 29: 983-996.
7. Cahan WG (1998) Radiation-induced sarcoma-50 years later. Cancer 82: 6-7.
8. Cahan WG, Woodard HQ, Higinbotham NL, Stewart FW, Coley BL (1948) Sarcoma arising in irradiated bone; report of 11 cases. Cancer 1: 3-29.
9. Collins BJ, Chiappetta G, Schneider AB, Santoro M, Pentimalli F, Fogelfeld L, Gierlowski T, Shore-Freedman E, Jaffe G, Fusco A (2002) RET expression in papillary thyroid cancer from patients irradiated in childhood for benign conditions. J Clin Endocrinol Metab 87: 3941-3946.
10. De Falco V, Castellone MD, De Vita G, Cirafici AM, Hershman JM, Guerrero C, Fusco A, Melillo RM, Santoro M (2007) RET/papillary thyroid carcinoma oncogenic signaling through the Rap1 small GTPase. Cancer Res 67: 381-390.
11. Fernandez AP, Sun Y, Tubbs RR, Goldblum JR, Billings SD (2012) FISH for MYC amplification and anti-MYC immunohistochemistry: useful diagnostic tools in the assessment of secondary angiosarcoma and atypical vascular proliferations. J Cutan Pathol 39: 234-242.
12. Guo T, Zhang L, Chang NE, Singer S, Maki RG, Antonescu CR (2011) Consistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions. Genes Chromosomes Cancer 50: 25-33.
13. Hadj-Hamou NS, Lae M, Almeida A, de la Grange P, Kirova Y, Sastre-Garau X, Malfoy B (2012) A transcriptome signature of endothelial lymphatic cells coexists with the chronic oxidative stress signature in radiation-induced post-radiotherapy breast angiosarcomas. Carcinogenesis 33: 1399-1405.
14. Herbst RS, Heymach JV, O'Reilly MS, Onn A, Ryan AJ (2007) Vandetanib (ZD6474): an orally available receptor tyrosine kinase inhibitor that selectively targets pathways critical for tumor growth and angiogenesis. Expert Opin Investig Drugs 16: 239-249.
15. Huang da W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
16. Joshi PP, Kulkarni MV, Yu BK, Smith KR, Norton DL, van Veelen W, Hoppener JW, Franklin DS (2007) Simultaneous downregulation of CDK inhibitors p18(Ink4c) and p27(Kip1) is required for MEN2A-RETmediated mitogenesis. Oncogene 26: 554-570.
17. Kacker C, Marx A, Mossinger K, Svehla F, Schneider U, Hogendoorn PC, Nielsen OS, Kuffer S, Sauer C, Fisher C, Hallermann C, Hartmann JT, Blay JY, Mechtersheimer G, Hohenberger P, Strobel P (2013) High frequency of MYC gene amplification is a common feature of radiation-induced sarcomas. Further results from EORTC STBSG TL 01/01. Genes Chromosomes Cancer 52: 93-98.
18. Karlsson P, Holmberg E, Samuelsson A, Johansson KA, Wallgren A (1998) Soft tissue sarcoma after treatment for breast cancer-a Swedish population-based study. Eur J Cancer 34: 2068-2075.
19. Kirova YM, Vilcoq JR, Asselain B, Sastre-Garau X, Fourquet A (2005) Radiation-induced sarcomas after radiotherapy for breast carcinoma: a large-scale single-institution review. Cancer 104: 856-863.
20. Koch S, Tugues S, Li X, Gualandi L, Claesson-Welsh L (2011) Signal transduction by vascular endothelial growth factor receptors. Biochem J 437: 169-183.
21. Kulkarni MV, Franklin DS (2011) N-Myc is a downstream target of RET signaling and is required for transcriptional regulation of p18(Ink4c) by the transforming mutant RET(C634R). Mol Oncol 5: 24-35.
22. Lipshutz GS, Brennan TV, Warren RS (2002) Thorotrast-induced liver neoplasia: a collective review. J Am Coll Surg 195: 713-718.
23. Maki RG, D'Adamo DR, Keohan ML, Saulle M, Schuetze SM, Undevia SD, Livingston MB, Cooney MM, Hensley ML, Mita MM, Takimoto CH, Kraft AS, Elias AD, Brockstein B, Blachere NE, Edgar MA, Schwartz LH, Qin LX, Antonescu CR, Schwartz GK (2009) Phase II study of sorafenib in patients with metastatic or recurrent sarcomas. J Clin Oncol 27: 3133-3140.
24. Manner J, Radlwimmer B, Hohenberger P, Mossinger K, Kuffer S, Sauer C, Belharazem D, Zettl A, Coindre JM, Hallermann C, Hartmann JT, Katenkamp D, Katenkamp K, Schoffski P, Sciot R, Wozniak A, Lichter P, Marx A, Strobel P (2010) MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema. Am J Pathol 176: 34-39.
25. Mark L, Delmore F, Creech Jr. JL, Ogden II LL, Fadell EH, Songster CL, Clanton J, Johnson MN, Christopherson WM (1976) Clinical and morphologic features of hepatic angiosarcoma in vinyl chloride workers. Cancer 37: 149-163.
26. Mentzel T, Schildhaus HU, Palmedo G, Buttner R, Kutzner H (2012) Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: clinicopathological, immunohistochemical and molecular analysis of 66 cases. Mod Pathol 25: 75-85.
27. Nascimento AF, Raut CP, Fletcher CD (2008) Primary angiosarcoma of the breast: clinicopathologic analysis of 49 cases, suggesting that grade is not prognostic. Am J Surg Pathol 32: 1896-1904.
28. Neuhaus SJ, Pinnock N, Giblin V, Fisher C, Thway K, Thomas JM, Hayes AJ (2009) Treatment and outcome of radiation-induced soft-tissue sarcomas at a specialist institution. Eur J Surg Oncol 35: 654-659.
29. Popper H, Thomas LB, Telles NC, Falk H, Selikoff IJ (1978) Development of hepatic angiosarcoma in man induced by vinyl chloride, thorotrast, and arsenic. Comparison with cases of unknown etiology. Am J Pathol 92: 349-376.
30. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, Sturn A, Snuffin M, Rezantsev A, Popov D, Ryltsov A, Kostukovich E, Borisovsky I, Liu Z, Vinsavich A, Trush V, Quackenbush J (2003) TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34: 374-378.
31. Seinen JM, Styring E, Verstappen V, Vult von Steyern F, Rydholm A, Suurmeijer AJ, Hoekstra HJ (2012) Radiation-associated angiosarcoma after breast cancer: high recurrence rate and poor survival despite surgical treatment with R0 resection. Ann Surg Oncol 19: 2700-2706.
32. Shon W, Ida CM, Boland-Froemming JM, Rose PS, Folpe A (2011) Cutaneous angiosarcoma arising in massive localized lymphedema of the morbidly obese: a report of five cases and review of the literature. J Cutan Pathol 38: 560-564.
33. Stewart FW, Treves N (1948) Lymphangiosarcoma in postmastectomy lymphedema; a report of six cases in elephantiasis chirurgica. Cancer 1: 64-81.
34. Styring E, Fernebro J, Jonsson PE, Ehinger A, Engellau J, Rissler P, Rydholm A, Nilbert M, Vult von Steyern F (2010) Changing clinical presentation of angiosarcomas after breast cancer: from late tumors in edematous arms to earlier tumors on the thoracic wall. Breast Cancer Res Treat 122: 883-887.
35. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121.
36. van Veelen W, van Gasteren CJ, Acton DS, Franklin DS, Berger R, Lips CJ, Hoppener JW (2008) Synergistic effect of oncogenic RET and loss of p18 on medullary thyroid carcinoma development. Cancer Res 68: 1329-1337.
37. Workman C, Jensen LJ, Jarmer H, Berka R, Gautier L, Nielser HB, Saxild HH, Nielsen C, Brunak S, Knudsen S (2002) A new non-linear normalization method for reducing variability in DNA microarray experiments. Genome Biol 3: research0048-research0048.16.